Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomasz Ciszewski

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Annals of Agricultural and Environmental Medicine : AAEM|December 29, 2015
Life quality of women with breast cancer after mastectomy or breast conserving therapy treated with adjuvant chemotherapyMarzena Kamińska, Tomasz Ciszewski, Bożena Kukiełka-Budny, et al.
Annals of Agricultural and Environmental Medicine : AAEM|December 23, 2014
Quality of life and occurrence of depression under chemotherapy in patients suffering from lung carcinomaBożena Baczewska, Marzena Kamińska, Tomasz Ciszewski, et al.
ESMO Open|October 24, 2020
Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapyDawid Sigorski, Paweł Sobczuk, Małgorzata Osmola, et al.
The Oncologist|January 23, 2026
Effectiveness of sacituzumab govitecan in metastatic triple-negative breast cancer: a real-world retrospective cohort study from Central EuropeMałgorzata Pieniążek, Anna Polakiewicz-Gilowska, Justyna Żubrowska, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 2, 2026
Combined positive score status in metastatic triple-negative breast cancer patients treated with sacituzumab govitecan: associated clinical characteristics and testing patterns in a Central European cohortKarolina Winsko-Szczęsnowicz, Małgorzata Pieniążek, Anna Polakiewicz-Gilowska, et al.
Oncology Research|June 4, 2026
Impact of Germline <i>BRCA1/2</i> Mutations on Clinical Outcomes in Metastatic Triple-Negative Breast Cancer Patients Treated with Sacituzumab Govitecan-An International CEBCC Study from Poland, the Czech Republic and SlovakiaRenata Pacholczak-Madej, Mirosława Püsküllüoğlu, Anna Polakiewicz-Gilowska, et al.
Breast (Edinburgh, Scotland)|January 21, 2026
Timing of final oncologist visit and systemic treatment use near the end of life in pretreated patients with metastatic triple-negative breast cancer: a multinational cohort studyJustyna Żubrowska, Małgorzata Pieniążek, Anna Polakiewicz-Gilowska, et al.
Cancers|May 11, 2024
Textbook Neoadjuvant Outcome-Novel Composite Measure of Oncological Outcomes among Gastric Cancer Patients Undergoing Multimodal TreatmentZuzanna Pelc, Katarzyna Sędłak, Magdalena Leśniewska, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Annals of Agricultural and Environmental Medicine : AAEM|December 29, 2015
Life quality of women with breast cancer after mastectomy or breast conserving therapy treated with adjuvant chemotherapyMarzena Kamińska, Tomasz Ciszewski, Bożena Kukiełka-Budny, et al.
Annals of Agricultural and Environmental Medicine : AAEM|December 23, 2014
Quality of life and occurrence of depression under chemotherapy in patients suffering from lung carcinomaBożena Baczewska, Marzena Kamińska, Tomasz Ciszewski, et al.
ESMO Open|October 24, 2020
Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapyDawid Sigorski, Paweł Sobczuk, Małgorzata Osmola, et al.
The Oncologist|January 23, 2026
Effectiveness of sacituzumab govitecan in metastatic triple-negative breast cancer: a real-world retrospective cohort study from Central EuropeMałgorzata Pieniążek, Anna Polakiewicz-Gilowska, Justyna Żubrowska, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 2, 2026
Combined positive score status in metastatic triple-negative breast cancer patients treated with sacituzumab govitecan: associated clinical characteristics and testing patterns in a Central European cohortKarolina Winsko-Szczęsnowicz, Małgorzata Pieniążek, Anna Polakiewicz-Gilowska, et al.
Oncology Research|June 4, 2026
Impact of Germline <i>BRCA1/2</i> Mutations on Clinical Outcomes in Metastatic Triple-Negative Breast Cancer Patients Treated with Sacituzumab Govitecan-An International CEBCC Study from Poland, the Czech Republic and SlovakiaRenata Pacholczak-Madej, Mirosława Püsküllüoğlu, Anna Polakiewicz-Gilowska, et al.
Breast (Edinburgh, Scotland)|January 21, 2026
Timing of final oncologist visit and systemic treatment use near the end of life in pretreated patients with metastatic triple-negative breast cancer: a multinational cohort studyJustyna Żubrowska, Małgorzata Pieniążek, Anna Polakiewicz-Gilowska, et al.
Cancers|May 11, 2024
Textbook Neoadjuvant Outcome-Novel Composite Measure of Oncological Outcomes among Gastric Cancer Patients Undergoing Multimodal TreatmentZuzanna Pelc, Katarzyna Sędłak, Magdalena Leśniewska, et al.
Pageof 2